Severe maternal morbidity in the Slovak Republic in the years 2012–2018
Authors:
M. Korbeľ 1
; A. Krištúfková 1
; Daniš J. 1; A. Adamec 1
; M. Vargová 1
; P. Kaščák 2
; Z. Nižňanská 1
Authors‘ workplace:
I. gynekologicko-pôrodnícka klinika LF UK a UN Bratislava, Slovenská republika
1; Gynekologicko-pôrodnícka klinika UAD a FN Trenčín, Slovenská republika
2
Published in:
Ceska Gynekol 2022; 87(2): 93-99
Category:
doi:
https://doi.org/10.48095/cccg202293
Overview
Objective: Analysis of maternal morbidity in the Slovak Republic in the years 2012–2018. Methods: The analysis of selected maternal morbidity data prospectively collected in the years 2012–2018 from all obstetric units in the Slovak Republic. Results: In the years 2012–2018, incidence of severe peripartum bleeding was 2.17, peripartum hysterectomy was 0.89, maternal admission to intensive care units was 1.59, eclampsia was 0.21, HELLP syndrome was 0.73, abnormally invasive placentation was 0.37, uterine rupture was 0.68, severe sepsis in pregnancy and puerperium was 0.18 and nonfatal amniotic fluid embolism was 0.027 per 1,000 births. Conclusion: Incidence of total severe acute maternal morbidity in the Slovak Republic was 6.84 per 1,000 births. In Slovak local conditions, there is still room for reduction of severe acute maternal morbidity.
Keywords:
severe acute maternal morbidity – severe peripartum haemorrhage – peripartum hysterectomy – eclampsia – HELLP syndrome – abnormally invasive placentation – uterine rupture – sepsis – amniotic fluid embolism – sepsis
Sources
1. Adamec A, Korbeľ M, Krištúfková A et al. Analýza prípadov peripartálnej hysterektómie v Slovenskej republike v rokoch 2012–2016. Gynekol prax 2020; 18 (2): 98–102.
2. Daniš J, Korbeľ M, Krištúfková A et al. Analýza prípadov závažného popôrodného krvácania v Slovenskej republike v rokoch 2012–2015. Gynekol prax 2018; 16 (1): 33–37.
3. Daniš J, Korbeľ M, Krištúfková A et al. Analýza prípadov závažného popôrodného krvácania v Slovenskej republike v roku 2016. Gynekol prax 2019; 17 (2): 91–95.
4. Daniš J, Korbeľ M, Krištúfková A et al. Analýza prípadov závažného popôrodného krvácania v Slovenskej republike v roku 2017. Gynekol prax 2020; 18 (2): 98–102.
5. Korbeľ M, Borovský M, Danko J et al. Regionálna analýza perinatálnych výsledkov v SR za rok 2007. Gynekol prax 2009; 7 (1): 9–14.
6. Korbeľ M, Borovský M, Danko J et al. Analýza perinatálnych výsledkov v SR za rok 2008. Gynekol prax 2010; 8 (1): 37–43.
7. Korbeľ M, Borovský M, Danko J et al. Analýza perinatálnych výsledkov v SR za rok 2009. Gynekol prax 2010; 8 (4): 193–199.
8. Korbeľ M, Borovský M, Danko J et al. Analýza perinatálnych výsledkov v SR za rok 2010. Gynekol prax 2011; 9 (2): 95–102
9. Korbeľ M, Borovský M, Danko J et al. Analýza perinatologických výsledkov Slovenskej republiky v rokoch 2007–2009. Ceska Gynekol 2011; 76 (1): 18–24.
10. Korbeľ M, Borovský M, Danko J et al. Analýza materskej morbidity v Slovenskej republike v roku 2011. Gynekol prax 2013; 11 (1): 20–24.
11. Korbeľ M, Borovský M, Danko J et al. Analýza materskej morbidity v Slovenskej republike v roku 2012. Gynekol prax 2014; 12 (1): 13–19.
12. Korbeľ M, Borovský M, Danko J et al. Analýza materskej morbidity v Slovenskej republike v roku 2013. Gynekol prax 2015; 13 (4): 160–166.
13. Korbeľ M, Borovský M, Danko J et al. Analýza materskej morbidity v Slovenskej republike v roku 2014. Gynekol prax 2016; 14 (2): 66–72.
14. Korbeľ M, Krištúfková A, Dugátová M et al. Analýza materskej morbidity v Slovenskej republike v roku 2015. Gynekol prax 2017; 15 (1): 18–24.
15. Korbeľ M, Krištúfková A, Dugátová M et al. Analýza materskej morbidity a mortality v Slovenskej republike v rokoch 2007–2012. Ceska Gynekol 2017; 82 (1): 6–15.
16. Korbeľ M, Krištúfková A, Dugátová M et al. Analýza materskej morbidity v Slovenskej republike v roku 2015. Gynekol prax 2017; 15 (1): 18–24.
17. Korbeľ M, Krištúfková A, Daniš J et al. Materská morbidita v Slovenskej republike v roku 2016. Gynekol prax 2018; 16 (1): 19–26.
18. Korbeľ M, Krištúfková A, Daniš J et al. Materská morbidita v Slovenskej republike v roku 2017. Gynekol prax 2019; 17 (2): 75–82.
19. Korbeľ M, Krištúfková A, Daniš J et al. Materská morbidita a mortalita v Slovenskej republike v rokoch 2007–2015. Ceska Gynekol 2019; 84 (2): 129–139.
20. Korbeľ M, Krištúfková A, Daniš J et al. Materská morbidita v Slovenskej republike v roku 2018. II. – perineálna a závažná materská morbidita. Gynekol prax 2020; 18 (2): 78–83.
21. Kristufkova A, Borovsky M, Korbel M et al. Amniotic fluid embolism – investigation of fatal cases in Slovakia in the years 2005–2010 compared with fatal cases in the United Kingdom. Biomed Pap med Fac Univ Palacky Olomouc Czech Repub 2014; 158 (3): 397–403. doi: 10.5507/bp.2013.050.
22. Krištúfková A, Korbeľ M, Borovský M et al. Analýza závažnej akútnej materskej morbidity v Slovenskej republike v roku 2012. Gynekol prax 2015; 13 (4): 185–191.
23. Krištúfková A, Korbeľ M, Daniš J et al. Analýza závažnej akútnej materskej morbidity v Slovenskej republike v roku 2015. Gynekol prax 2016; 14 (2): 92–98.
24. Krištúfková A, Korbeľ M, Daniš J et al. Analýza závažnej akútnej materskej morbidity v Slovenskej republike v roku 2014. Gynekol prax 2017; 15 (1): 25–32.
25. Krištúfková A, Korbeľ M, Daniš J et al. Analýza závažnej akútnej materskej morbidity v Slovenskej republike v rokoch 2016 a 2017. Gynekol prax 2020; 18 (2): 93–97.
26. Lévayová B, Korbeľ M, Krištúfková A et al. Analýza prípadov abnormálnej invázie placenty v Slovenskej republike v rokoch 2012–2015. Gynekol prax 2019; 17 (2): 96–99.
27. Vargová M, Korbeľ M, Adamec A et al. Analýza prípadov transportu rodičiek na jednotky intenzívnej starostlivosti v Slovenskej republike v rokoch 2014–2016. Gynekol prax 2020; 18 (2): 104–108.
28. Vargová M, Korbeľ M, Adamec A et al. Transport rodičiek na jednotky intenzívnej starostlivosti – medzinárodné porovnanie Slovenskej republiky. Gynekol prax 2021; 19 (2): 108–112.
29. Fitzpatrick KE, Tuffnell D, Kurinczuk JJ et al. Incidence, risk factors, management and outcomes of amniotic–fluid embolism: a population-based cohort and nested case-control study. BJOG 2016; 123 (1): 100–109. doi: 10.1111/1471-0528.13300.
30. Fitzpatrick KE, van den Akker T, Bloemenkamp K et al. Risk factors, management, and outcomes of amniotic fluid embolism: a multicountry, population-based cohort and nested case-control study. PLoS Med 2019; 16 (11): e1002962. doi: 10.1371/journal.pmed.1002 962.
31. Kallianidis A, Maraschini A, Danis J et al. Epidemiological analysis of peripartum hysterectomy across nine European countries. Acta Obstet Gynecol Scand 2020; 99 (10): 1364–1373. doi: 10.1111/aogs.13892.
32. Kallianidis A, Maraschini A, Danis J et al. Management of major obstetric hemorrhage prior to peripartum hysterectomy and outcomes across nine European countries. Acta Obstet Gynecol Scand 2021; 100 (7): 1345–1354. doi: 10.1111/aogs.14113.
33. Knight M. The International Network of Obstetric Survey System (INOSS): benefits of multi-country studies of severe and uncommon maternal morbidities. Acta Obstet Gynecol Scand 2014; 93 (2): 127–131. doi: 10.1111/aogs. 12316.
34. Schaap T, Bloemenkamp C, Deneux-Tharaux C et al. Defining definitions: a Delphi study to develop a core outcome set for conditions of severe maternal morbidity. BJOG 2019; 126 (3): 394–401. doi: 10.1111/1471-0528.14 833.
35. Euro-Peristat Project with SCPE, EUROCAT, EURONEOSTAT. European Perinatal Health Report 2008. 2004 [online]. Available from: www.europeristat.com.
36. Euro-Peristat Project with SCPE and EUROCAT. European Perinatal Health Report. Health and care of pregnant women and babies in Europe in 2010. 2013 [online]. Available from: www.europeristat.com.
37. Euro-Peristat Project. European Perinatal Health Report. Core indicators of the health and care of pregnant women and babies in Europe in 2015. 2018 [online]. Available from: www.europeristat.com.
38. Zwart JJ, Richters JM, Ory F et al. Severe maternal morbidity during pregnancy, delivery and puerperium in the Netherlands: a nationwide population-based study of 371,000 pregnancies. BJOG 2008; 115 (7): 842–850. doi: 10.1111/j.1471-0528.2008.01713.x.
39. Carroli G, Guesta C, Abalos E et al. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol 2008; 22 (6): 999–1012. doi: 10.1016/j.bpobgyn.2008.08.004.
40. Deneux-Tharaux C, Dupont C, Colin C et al. Multifaceted intervention to decrease the rate of severe postpartum haemorrhage: the PITHAGORE6 cluster-randomised controlled trial. BJOG 2010; 117 (10): 1278–1287. doi: 10.1111/j.1471-0528.2010.02648.x.
41. Knight M, UKOSS. Eclampsia in the United Kingdom 2005. BJOG 2007; 114 (9): 1072–1078. doi: 10.1111/j.1471-0528.2007.01423.x.
42. Garmi G, Salim R. Epidemiology, etiology, diagnosis, and management of placenta accreta. Obstet Gynecol Int 2012; 2012: 873929. doi: 10.1155/2012/873929.
43. Fitzpatrick KE, Sellers S, Spark P et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One 2012; 7 (12): e52893. doi: 10.1371/journal.pone.0052893.
44. Kayem G, Anselem O, Schmitz T et al. Conservative versus radical management in cases of placenta accreta: a historical study. J Gynecol Obstet Biol Reprod 2007; 36 (7): 680–687. doi: 10.1016/j.jgyn.2007.05.002.
45. Sentilhes L, Kayem G, Ambroselli C et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum Reprod 2010; 25 (11): 2803–2810. doi: 10.1093/humrep/deq239.
46. Hofmeyr GJ, Say L, Gülmezoglu AM. WHO systematic review of maternal mortality and morbidity: the prevalence of uterine rupture. BJOG 2005; 112 (9): 1221–1228. doi: 10.1111/j.1471- 0528.2005.00725.x.
47. Fitzpatrick KE, Kurinczuk JJ, Alfirevic Z et al. Uterine rupture by intended mode of delivery in the UK: a national case-control study. PLoS Med 2012; 9 (3): e1001184. doi: 10.1371/journal.pmed.1001184.
48. Vandenberghe G, Bloemenkamp K, Berlage S et al. The International Network of Obstetric Survey Systems study of uterine rupture: a descriptive multi-country population-based study. BJOG 2019; 126 (3): 370–381. doi: 10.1111/1471-0528.15271.
49. Chen L, Wang Q, Gao Y et al. The global burden and trends of maternal sepsis and other maternal infections in 204 countries and territories from 1990 to 2019. BMC Infect Dis 2021; 21 (1): 1074. doi: 10.1186/s12879-021-067 79-0.
50. van Dillen J, Zwart J, Schuttec J et al. Maternal sepsis: epidemiology, etiology and outcome. Curr Opin Infect Dis 2010; 23 (3): 249–254. doi: 10.1097/QCO.0b013e328339257c
51. Who Global Maternal Sepsis Study (GLOSS) Research Group. Frequency and management of maternal infection in health facilities in 52 countries (GLOSS): a 1-week inception cohort study. Lancet Glob Health 2020; 8 (5): e661–e671. doi: 10.1016/S2214-109X (20) 30109-1.
Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineArticle was published in
Czech Gynaecology
2022 Issue 2
Most read in this issue
- Current data on the efficacy of prophylactic HPV vaccination in the primary prevention of cervical lesions
- Hymenal atresia – a rare congenital anomaly with the risk of late diagnosis
- Assisted reproduction in patients with Klinefelter syndrome
- Maternal mortality in the Slovak Republic in the years 2007–2018